Preventing the introduction of meticillin-resistant Staphylococcus aureus into hospitals

J. Larsen; M.Z. David; M.C. Vos; G.W. Coombs; H. Grundmann; S. Harbarth; A. Voss; R.L. Skov

doi:10.1016/j.jgar.2014.09.003

Back

Preventing the introduction of meticillin-resistant Staphylococcus aureus into hospitals

Journal article

Peer reviewed

Preventing the introduction of meticillin-resistant Staphylococcus aureus into hospitals

J. Larsen, M.Z. David, M.C. Vos, G.W. Coombs, H. Grundmann, S. Harbarth, A. Voss and R.L. Skov

Journal of Global Antimicrobial Resistance, Vol.2(4), pp.260-268

2014

DOI: https://doi.org/10.1016/j.jgar.2014.09.003

Files and links (1)

url

Link to Published Version *Subscription may be requiredView

Abstract

The objective of this review was to provide an up-to-date account of the interventions used to prevent the introduction of meticillin-resistant Staphylococcus aureus (MRSA) from the expanding community and livestock reservoirs into hospitals in the USA, Denmark, The Netherlands and Western Australia. A review of existing literature and local guidelines for the management of MRSA in hospitals was performed. In Denmark, The Netherlands and Western Australia, where the prevalence of MRSA is relatively low, targeted admission screening and isolation of predefined high-risk populations have been used for several decades to successfully control MRSA in the hospital. Furthermore, in Denmark and The Netherlands, all identified MRSA carriers undergo routine decolonisation, whereas only carriers of particularly transmissible or virulent MRSA clones are subjected to decolonisation in Western Australia. In the USA, which continues to be a high-prevalence MRSA country, policies vary by state and even by hospital, and whilst guidelines from professional organisations provide a framework for infection control practices, these guidelines lack the authority of a legislative mandate. In conclusion, the changing epidemiology of MRSA, exemplified by the recent emergence of MRSA in the community and in food animals, makes it increasingly difficult to accurately identify specific high-risk groups to screen for MRSA carriage. Understanding the changing epidemiology of MRSA in a local as well as global context is fundamental to prevent the introduction of MRSA into hospitals.

Details

Title: Preventing the introduction of meticillin-resistant Staphylococcus aureus into hospitals
Authors/Creators: J. Larsen (Author/Creator) - Statens Serum Institut
M.Z. David (Author/Creator) - University of Chicago
M.C. Vos (Author/Creator) - Erasmus MC
G.W. Coombs (Author/Creator) - Curtin University
H. Grundmann (Author/Creator) - University Medical Center Groningen
S. Harbarth (Author/Creator) - Infection Control Program and Division of Infectious Diseases, Geneva University Hospitals and Medical School, Geneva, Switzerland
A. Voss (Author/Creator) - Radboud University Medical Center
R.L. Skov (Author/Creator) - Statens Serum Institut
Publication Details: Journal of Global Antimicrobial Resistance, Vol.2(4), pp.260-268
Publisher: Elsevier BV
Identifiers: 991005542444807891
Copyright: © 2014 International Society for Chemotherapy of Infection and Cancer.
Murdoch Affiliation: Murdoch University
Language: English
Resource Type: Journal article

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Metrics

39 Record Views

11 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.23 Antibiotics & Antimicrobials; 1.23.173 MRSA and VRE
Web Of Science research areas: Infectious Diseases; Pharmacology & Pharmacy
ESI research areas: Immunology